KATILYN JONES: Open Payments
NPI 1093570996 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 12 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $41 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $99 |
| ViiV Healthcare Company | 4 | $94 |
| Edwards Lifesciences Corporation | 1 | $72 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| Gilead Sciences, Inc. | 2 | $40 |
| Novo Nordisk Inc | 2 | $33 |
Products named: ULTOMIRIS, SAPIEN 3 Ultra RESILIA, APRETUDE, PIFELTRO, RUKOBIA, DOVATO, Ozempic, Rybelsus.
Industry payments across MS — which companies pay providers there.
